Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 13 | 2023 | 573 | 3.120 |
Why?
|
| Alzheimer Disease | 11 | 2023 | 316 | 2.760 |
Why?
|
| Pneumonia, Viral | 5 | 2020 | 169 | 2.720 |
Why?
|
| Coronavirus Infections | 5 | 2020 | 176 | 2.680 |
Why?
|
| Apathy | 10 | 2023 | 42 | 2.330 |
Why?
|
| Pandemics | 8 | 2023 | 553 | 2.030 |
Why?
|
| Depressive Disorder | 5 | 2020 | 336 | 1.360 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2020 | 70 | 1.330 |
Why?
|
| Occupational Exposure | 2 | 2021 | 113 | 1.290 |
Why?
|
| Methylphenidate | 6 | 2023 | 76 | 1.280 |
Why?
|
| Anxiety | 2 | 2020 | 285 | 1.140 |
Why?
|
| Exercise Therapy | 2 | 2019 | 95 | 1.080 |
Why?
|
| Activities of Daily Living | 6 | 2023 | 175 | 1.000 |
Why?
|
| Cognition Disorders | 3 | 2012 | 211 | 0.910 |
Why?
|
| Caregivers | 4 | 2020 | 223 | 0.900 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 43 | 0.840 |
Why?
|
| Accidental Falls | 2 | 2017 | 106 | 0.800 |
Why?
|
| Videoconferencing | 2 | 2020 | 37 | 0.800 |
Why?
|
| Aged | 26 | 2023 | 9738 | 0.790 |
Why?
|
| Walking | 4 | 2020 | 100 | 0.770 |
Why?
|
| World War II | 1 | 2021 | 11 | 0.750 |
Why?
|
| Awards and Prizes | 1 | 2021 | 18 | 0.740 |
Why?
|
| Narration | 1 | 2021 | 27 | 0.740 |
Why?
|
| Cognition | 5 | 2018 | 342 | 0.710 |
Why?
|
| Social Isolation | 2 | 2021 | 28 | 0.700 |
Why?
|
| Air Pollutants, Occupational | 1 | 2020 | 17 | 0.700 |
Why?
|
| Rural Health | 1 | 2020 | 89 | 0.670 |
Why?
|
| Fear | 2 | 2020 | 83 | 0.670 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2012 | 138 | 0.670 |
Why?
|
| Research Subjects | 1 | 2020 | 50 | 0.650 |
Why?
|
| Humans | 45 | 2023 | 50419 | 0.630 |
Why?
|
| Double-Blind Method | 9 | 2023 | 710 | 0.630 |
Why?
|
| Executive Function | 2 | 2018 | 75 | 0.620 |
Why?
|
| Male | 31 | 2023 | 25866 | 0.620 |
Why?
|
| Music | 1 | 2018 | 5 | 0.620 |
Why?
|
| Time Perception | 1 | 2018 | 28 | 0.610 |
Why?
|
| Auditory Perception | 1 | 2018 | 29 | 0.610 |
Why?
|
| Military Personnel | 1 | 2020 | 163 | 0.600 |
Why?
|
| Stress, Psychological | 1 | 2020 | 268 | 0.600 |
Why?
|
| Postural Balance | 2 | 2017 | 57 | 0.600 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2018 | 30 | 0.590 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 86 | 0.590 |
Why?
|
| Telemedicine | 2 | 2020 | 468 | 0.550 |
Why?
|
| Sensation Disorders | 1 | 2017 | 10 | 0.540 |
Why?
|
| Biomedical Research | 1 | 2020 | 243 | 0.540 |
Why?
|
| User-Computer Interface | 2 | 2018 | 78 | 0.500 |
Why?
|
| Depression | 2 | 2020 | 577 | 0.490 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 3233 | 0.490 |
Why?
|
| Independent Living | 4 | 2020 | 43 | 0.480 |
Why?
|
| Dementia | 3 | 2023 | 146 | 0.470 |
Why?
|
| Central Nervous System Stimulants | 4 | 2020 | 209 | 0.460 |
Why?
|
| Pilot Projects | 5 | 2023 | 694 | 0.410 |
Why?
|
| Loneliness | 3 | 2021 | 12 | 0.390 |
Why?
|
| Vaccines | 1 | 2023 | 50 | 0.380 |
Why?
|
| Female | 18 | 2023 | 27053 | 0.370 |
Why?
|
| Video Games | 1 | 2011 | 13 | 0.360 |
Why?
|
| Mianserin | 1 | 2010 | 10 | 0.340 |
Why?
|
| Hallucinations | 1 | 2010 | 19 | 0.340 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2010 | 27 | 0.340 |
Why?
|
| Middle Aged | 13 | 2022 | 12579 | 0.340 |
Why?
|
| Weight Loss | 2 | 2012 | 245 | 0.320 |
Why?
|
| Citalopram | 2 | 2012 | 18 | 0.290 |
Why?
|
| Resistance Training | 3 | 2018 | 100 | 0.280 |
Why?
|
| Appetite Stimulants | 1 | 2007 | 5 | 0.270 |
Why?
|
| Nutrition Disorders | 1 | 2007 | 14 | 0.270 |
Why?
|
| Antipsychotic Agents | 2 | 2022 | 233 | 0.270 |
Why?
|
| Urinary Retention | 1 | 2006 | 7 | 0.270 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 2231 | 0.270 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 1601 | 0.270 |
Why?
|
| Long-Term Care | 1 | 2007 | 50 | 0.270 |
Why?
|
| Simvastatin | 1 | 2006 | 29 | 0.260 |
Why?
|
| Quinolones | 1 | 2006 | 42 | 0.260 |
Why?
|
| Exercise | 2 | 2020 | 513 | 0.250 |
Why?
|
| Dietary Supplements | 3 | 2018 | 449 | 0.250 |
Why?
|
| Piperazines | 1 | 2006 | 120 | 0.250 |
Why?
|
| Antidepressive Agents | 2 | 2020 | 176 | 0.240 |
Why?
|
| Arkansas | 2 | 2021 | 1974 | 0.240 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2023 | 24 | 0.230 |
Why?
|
| Prospective Studies | 5 | 2020 | 2378 | 0.230 |
Why?
|
| Treatment Outcome | 8 | 2023 | 5265 | 0.230 |
Why?
|
| Diet | 1 | 2007 | 564 | 0.200 |
Why?
|
| Muscle, Skeletal | 3 | 2018 | 786 | 0.200 |
Why?
|
| Time Factors | 4 | 2018 | 2933 | 0.200 |
Why?
|
| Lithium | 1 | 2022 | 34 | 0.190 |
Why?
|
| Risk Factors | 4 | 2022 | 3712 | 0.190 |
Why?
|
| Energy Intake | 2 | 2012 | 176 | 0.190 |
Why?
|
| Patient Acuity | 2 | 2022 | 17 | 0.190 |
Why?
|
| Incineration | 1 | 2021 | 5 | 0.180 |
Why?
|
| Suicide, Attempted | 1 | 2022 | 76 | 0.180 |
Why?
|
| Hypesthesia | 1 | 2020 | 16 | 0.180 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 24 | 0.170 |
Why?
|
| Electronic Mail | 1 | 2020 | 17 | 0.170 |
Why?
|
| Memory Disorders | 1 | 2020 | 53 | 0.170 |
Why?
|
| Medical Staff | 1 | 2020 | 4 | 0.170 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 150 | 0.170 |
Why?
|
| Geriatrics | 1 | 2020 | 47 | 0.170 |
Why?
|
| Jogging | 1 | 2020 | 2 | 0.170 |
Why?
|
| Trazodone | 1 | 2020 | 6 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 170 | 0.170 |
Why?
|
| Bipolar Disorder | 1 | 2022 | 195 | 0.170 |
Why?
|
| Affective Symptoms | 1 | 2020 | 21 | 0.170 |
Why?
|
| Research Personnel | 1 | 2020 | 65 | 0.160 |
Why?
|
| Patient Safety | 1 | 2020 | 102 | 0.160 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 224 | 0.160 |
Why?
|
| Parkinson Disease | 1 | 2021 | 161 | 0.150 |
Why?
|
| Adult | 5 | 2023 | 13561 | 0.150 |
Why?
|
| Thigh | 1 | 2018 | 33 | 0.150 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 383 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2018 | 6 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 105 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 305 | 0.140 |
Why?
|
| Medication Therapy Management | 1 | 2018 | 23 | 0.140 |
Why?
|
| Geriatric Assessment | 4 | 2015 | 115 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 135 | 0.140 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 16 | 0.140 |
Why?
|
| Hospitalization | 2 | 2022 | 677 | 0.140 |
Why?
|
| Video Recording | 1 | 2017 | 84 | 0.130 |
Why?
|
| Rehabilitation Centers | 2 | 2012 | 34 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 136 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2020 | 1268 | 0.120 |
Why?
|
| Immune System | 1 | 2015 | 43 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 91 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2015 | 111 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 515 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1085 | 0.110 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 346 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 1163 | 0.100 |
Why?
|
| Hospital Units | 1 | 2012 | 10 | 0.100 |
Why?
|
| Physical Endurance | 1 | 2012 | 31 | 0.100 |
Why?
|
| Leg | 1 | 2012 | 123 | 0.100 |
Why?
|
| Edema | 1 | 2012 | 69 | 0.100 |
Why?
|
| Aging | 2 | 2018 | 692 | 0.100 |
Why?
|
| Young Adult | 2 | 2022 | 4075 | 0.090 |
Why?
|
| Cholesterol | 1 | 2012 | 150 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2012 | 191 | 0.090 |
Why?
|
| Brain | 1 | 2020 | 1318 | 0.090 |
Why?
|
| Malnutrition | 1 | 2012 | 85 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 549 | 0.090 |
Why?
|
| Nutrition Assessment | 2 | 2012 | 63 | 0.090 |
Why?
|
| Weight Gain | 1 | 2012 | 235 | 0.090 |
Why?
|
| Asymptomatic Diseases | 1 | 2021 | 38 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2022 | 462 | 0.090 |
Why?
|
| Adolescent | 2 | 2022 | 6453 | 0.080 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 416 | 0.080 |
Why?
|
| Dietary Proteins | 1 | 2012 | 251 | 0.080 |
Why?
|
| Inflammation | 1 | 2012 | 607 | 0.070 |
Why?
|
| Incidence | 1 | 2021 | 1027 | 0.070 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2006 | 7 | 0.070 |
Why?
|
| Syndrome | 2 | 2020 | 236 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 387 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2006 | 258 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2020 | 6274 | 0.060 |
Why?
|
| Fructose | 1 | 2023 | 22 | 0.050 |
Why?
|
| Aftercare | 1 | 2023 | 72 | 0.050 |
Why?
|
| Antimanic Agents | 1 | 2022 | 14 | 0.050 |
Why?
|
| Acetylcholinesterase | 1 | 2021 | 18 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2022 | 96 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2023 | 318 | 0.040 |
Why?
|
| Geriatric Psychiatry | 1 | 2020 | 9 | 0.040 |
Why?
|
| Europe | 1 | 2020 | 80 | 0.040 |
Why?
|
| Receptors, Dopamine | 1 | 2020 | 21 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2020 | 50 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2020 | 69 | 0.040 |
Why?
|
| Gait | 1 | 2020 | 89 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 242 | 0.040 |
Why?
|
| Organ Size | 1 | 2018 | 225 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2018 | 47 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 91 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2018 | 86 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 230 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 192 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 621 | 0.030 |
Why?
|
| United States | 2 | 2018 | 5005 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 567 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2015 | 34 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2018 | 481 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2015 | 110 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 976 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 389 | 0.030 |
Why?
|
| Intermediate Care Facilities | 1 | 2012 | 4 | 0.030 |
Why?
|
| Prealbumin | 1 | 2012 | 21 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2012 | 57 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 107 | 0.020 |
Why?
|
| Fluoxetine | 1 | 2012 | 42 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2012 | 134 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 145 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 261 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 386 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 517 | 0.020 |
Why?
|
| Rural Population | 1 | 2015 | 556 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2012 | 447 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 281 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1451 | 0.020 |
Why?
|